| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18807128 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Uemura N, Inokuchi H, Serizawa H, et al.
Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease. [Journal Article]
J Gastroenterol 2008; 43(9):670-8.
Abstract | Full Citation | Find Related Articles | | Kinoshita Y, Kobayashi T, Kato M, et al.
The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan. [Journal Article]
J Gastroenterol 2006 Jun; 41(6):554-61.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Richter JE, Peura D, Benjamin SB, et al.
Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Arch Intern Med 2000 Jun 26; 160(12):1810-6.
Abstract | Full Citation | Find Related Articles | | Hongo M, Kinoshita Y, Haruma K
A randomized, double-blind, placebo-controlled clinical study of the histamine H(2)-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease. [JOURNAL ARTICLE]
J Gastroenterol 2008 Jun; 43(6):448-456.
Abstract | Full Citation | Find Related Articles | | Bate CM, Green JR, Axon AT, et al.
Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 1997 Aug; 11(4):755-63.
Abstract | Full Citation | Find Related Articles | | Sontag SJ, Hirschowitz BI, Holt S, et al.
Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the U.S. Multicenter Study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't ]
Gastroenterology 1992 Jan; 102(1):109-18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Miner P, Orr W, Filippone J, et al.
Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Gastroenterol 2002 Jun; 97(6):1332-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hatlebakk JG, Hyggen A, Madsen PH, et al.
Heartburn treatment in primary care: randomised, double blind study for 8 weeks. [Clinical Trial, Journal Article, Randomized Controlled Trial]
BMJ 1999 Aug 28; 319(7209):550-3.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Dekkers CP, Beker JA, Thjodleifsson B, et al.
Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 1999 Jan; 13(1):49-57.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
